Freedom Investment Management, Inc. - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 165 filers reported holding AMNEAL PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
Freedom Investment Management, Inc. ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$51,000
-28.2%
13,090
-11.9%
0.01%
-25.0%
Q2 2020$71,000
-9.0%
14,855
-7.3%
0.01%
+14.3%
Q1 2020$78,000
+1.3%
16,033
+0.9%
0.01%0.0%
Q4 2019$77,000
+51.0%
15,890
-9.1%
0.01%
+75.0%
Q3 2019$51,000
-65.1%
17,474
-14.2%
0.00%
-66.7%
Q2 2019$146,000
-54.4%
20,365
-9.9%
0.01%
-53.8%
Q1 2019$320,000
-13.7%
22,613
-17.5%
0.03%
-10.3%
Q4 2018$371,000
-46.3%
27,398
-6.8%
0.03%
-32.6%
Q3 2018$691,000
+46.1%
29,391
+2.0%
0.04%
+53.6%
Q2 2018$473,00028,8090.03%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$144,839,00011.40%
Eversept Partners, LP 4,755,480$32,004,3802.41%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$109,116,0001.27%
EAM Global Investors LLC 365,719$2,461,0000.68%
Signature Wealth Management Partners, LLC 87,666$590,0000.57%
Jackson Creek Investment Advisors LLC 221,043$1,488,0000.52%
Tranquilli Financial Advisor LLC 71,414$481,0000.39%
Hillsdale Investment Management Inc. 611,200$4,113,0000.34%
EAM Investors, LLC 259,873$1,749,0000.26%
HUSSMAN STRATEGIC ADVISORS, INC. 180,000$1,211,0000.25%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders